Back to search
Fibrolamellar Hepatocellular Carcinoma (FLC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrolamellar Hepatocellular Carcinoma (FLC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrolamellar Hepatocellular Carcinoma (FLC) trials you may qualify forThe purpose of this study is to determine whether the combination of subcutaneous DRP-104 in combination with intravenous Durvalumab is safe and yields a clinic…
The aim of this clinical trial is to evaluate the immunogenicity along with safety and toxicity as well as first efficacy of a DNAJB1-PRKACA fusion transcript-b…
The primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with nivo…
The purpose of this study is to determine whether the combination of a neoantigen vaccine targeting the DNAJB1-PRKACA fusion kinase in combination with DRP-104,…
The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world.…
The purpose of the study is to determine whether once-daily dosing with ENMD-2076 will be a safe and effective treatment in patients with FLC. Safety will be me…